Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.52 |
| ▸ | SQLE | Q14534 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | FNTA | P49354 | 1/20 | 0.47 |
| ▸ | FNTB | P49356 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11584608 | 1.00 | KMT2A (0.58) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL11586065 | 1.00 | KMT2A (0.58) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Water SCHEMBL9280359 | 0.98 | KMT2A (0.56) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL6664660 | 0.96 | KMT2A (0.67) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL808086 | 0.84 | KMT2A (0.56) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL1616971 | 0.84 | KMT2A (0.56) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL1617090 | 0.84 | KMT2A (0.56) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL795270 | 0.82 | KMT2A (0.54) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL7687531 | 0.82 | KMT2A (0.54) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL30560064 | 0.82 | KMT2A (0.54) | KMT2AMEN1CYP3A4ALOX15MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117982698-A | Vehicle-mounted fragrance and preparation method thereof | 广州汽车集团股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| US-6506793-B2 | For sustained release of lemon aroma unique to citral; perfumes; leucine dehydrogenase inhibitors; deodorants, cosmetics, dermatology agents | KAO CORPORATION (JP) | 2003-01-14 | — | — | US | claimed |
| US-20020068075-A1 | Citral Acetal | KAO CORPORATION (JP) | 2002-06-06 | — | — | US | claimed |
| US-6239087-B1 | COMPOSITIONS CONTAINING CERTAIN ACETALS OR KETALS WHICH HYDROLYZE UPON EXPOSURE OF SURFACES WASHED IN SOLUTION OF SAID COMPOSITIONS TO REDUCTION IN PH, THEREBY RELEASING FRAGRANCE CHARACTERISTIC OF ONE OR MORE OF HYDROLYSIS PRODUCTS | THE PROCTER & GAMBLE COMPANY | 2001-05-29 | — | — | US | claimed |
| EP-0888439-A1 | DETERGENT COMPOSITIONS CONTAINING FRAGRANCE PRECURSORS AND THE FRAGRANCE PRECURSORS THEMSELVES | THE PROCTER & GAMBLE COMPANY (US) | 1999-01-07 | — | — | EP | claimed |
| WO-1997034986-A1 | DETERGENT COMPOSITIONS CONTAINING FRAGRANCE PRECURSORS AND THE FRAGRANCE PRECURSORS THEMSELVES | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-25 | — | — | WO | claimed |
| US-5466721-A | Citral acetal ethers of alpha-hydroxy phenyl ketones and radiation curable compositions thereof | HENKEL CORPORATION (US) | 1995-11-14 | — | — | US | claimed |
| WO-1994029355-A1 | CITRAL ACETAL ETHERS OF ALPHA-HYDROXY PHENYL KETONES AND POLYMERIZABLE COMPOSITIONS | HENKEL CORPORATION (US) | 1994-12-22 | — | — | WO | claimed |
| US-4832059-A | ADDING CITRAL ACETAL AND AGING | LORILLARD, INC. (US) | 1989-05-23 | — | — | US | claimed |
| CN-118076767-A | Method and formulation for producing an optical metal oxide layer | 默克专利有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-117982698-A | Vehicle-mounted fragrance and preparation method thereof | 广州汽车集团股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| US-20210330667-A1 | TOPICAL COMPOSITION OF NALBUPHINE AND METHOD FOR TREATING PRURITUS CONDITION, PAIN, OR INFLAMMATORY CONDITION BY USING THE SAME | LUMOSA THERAPEUTICS CO., LTD. (TW) | 2021-10-28 | — | — | US | disclosed |
| US-20190002722-A1 | FORMULATIONS CONTAINING A MIXTURE OF AT LEAST TWO DIFFERENT SOLVENTS | MERCK PATENT GMBH (DE) | 2019-01-03 | — | — | US | disclosed |
| EP-3390550-A1 | FORMULATIONS CONTAINING A MIXTURE OF AT LEAST TWO DIFFERENT SOLVENTS | Merck Patent GmbH (DE) | 2018-10-24 | — | — | EP | disclosed |
| US-5426247-A | CONDENSATION OF CYCLOGERANL SULFONE, HALOGENATION, REMOVING SULFONE AND HALOGN, DEACETALIZATION, ISOMERIZATION | RHONE-POULENC NUTRITION ANIMALE (FR) | 1995-06-20 | — | — | US | disclosed |
| WO-1994029355-A1 | CITRAL ACETAL ETHERS OF ALPHA-HYDROXY PHENYL KETONES AND POLYMERIZABLE COMPOSITIONS | HENKEL CORPORATION (US) | 1994-12-22 | — | — | WO | disclosed |
| EP-0343234-A1 | CITRUS-FLAVORED TOBACCO ARTICLES | LORILLARD, INC. (US) | 1989-11-29 | — | — | EP | disclosed |
| WO-1989005102-A1 | CITRUS-FLAVORED TOBACCO ARTICLES | LORILLARD, INC. (US) | 1989-06-15 | — | — | WO | disclosed |
| US-4832059-A | ADDING CITRAL ACETAL AND AGING | LORILLARD, INC. (US) | 1989-05-23 | — | — | US | disclosed |
| US-4832059-A | ADDING CITRAL ACETAL AND AGING | LORILLARD, INC. (US) | 1989-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068075-A1 | Citral Acetal | LDHA, LDHB, ALDH1A1 | KMT2A 2545/4885MEN1 2261/4885CYP3A4 515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.